Skip to main content

Search

Reset all filters
46 Result(s)
Sort by

Innovation in Oncology and Cancer Immunology Research

Innovation in Oncology and Cancer Immunology Research

We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
Lung Cancer

Lung Cancer

Building on our experience in lung disease, our goal is to take lung cancer on, transform the treatment landscape and ultimately, redefine all lung cancers as curable.
Biotherapeutics Discovery

Biotherapeutics Discovery

Our committed team of scientists are using all their experience and knowledge to forge new research paths, engineer new molecules and do whatever it takes to make sure that no patient is left behind in our search for the next breakthrough.
Our innovation strategy

Our innovation strategy

Our Innovation Strategy at Boehringer Ingelheim in Research and Development
Regional Center Vienna

Regional Center Vienna

RCV is the regional affiliate of Boehringer Ingelheim and responsible for over 30 countries in Central and Eastern Europe and Central Asia.
Embracing diversity in clinical trials: A global mandate

Embracing diversity in clinical trials: A global mandate

Have you ever wondered why medicines work differently for different people? Each patient is unique. By embracing diversity in clinical trials, we enable more equitable and inclusive healthcare.